Monday, 22 December 2014

FDA approves AbbVie combo hepatitis C treatment

TRENTON, N.J. (AP) — Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie. via Health News Headlines - Yahoo News Read More Here..

No comments:

Post a Comment